Kiwi Wealth Investments Limited Partnership Intra Cellular Therapies, Inc. Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 17, 2022	SELL	$38.74 - $62.09 $789,831 - $1.27 Million	-20,388 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$35.2 - $53.42 $717,657 - $1.09 Million	20,388 New	20,388 $1.07 Million

Others Institutions Holding ITCI

# of Institutions

381

Shares Held

84M

Call Options Held

319K

Put Options Held

143K

Vanguard Group Inc Valley Forge, PA

9.63M
Shares

$1.22 Billion
0.01% of portfolio
Black Rock Inc. New York, NY

6.32M
Shares

$798 Million
0.01% of portfolio
Jpmorgan Chase & CO New York, NY

5.29M
Shares

$667 Million
0.03% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

3.85M
Shares

$486 Million
1.4% of portfolio
Avoro Capital Advisors LLC New York, NY

3.05M
Shares

$385 Million
3.36% of portfolio

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $11.9B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account